| Phase 1 | 2 | |
| Phase 3 | 4 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT01946204 | A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate… | Prostatic Neoplasms | Active, Not Recruiting | 2026-09-28 |
| NCT02257736 | An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With… | Prostatic Neoplasms | Active, Not Recruiting | 2026-09-28 |
| NCT02489318 | A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT)… | Prostate Cancer | Active, Not Recruiting | 2026-09-28 |
| NCT02531516 | An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer… | Prostatic Neoplasms | Active, Not Recruiting | 2026-09-25 |
| Phase 1 | ||||
| NCT02123758 | A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic… | Prostatic Neoplasms | Active, Not Recruiting | 2026-09-25 |
| NCT02592317 | A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics… | Prostatic Neoplasms, Castration-Resistant | Active, Not Recruiting | 2026-09-25 |
Prostate Cancer (6)